Clinical Trial Update: Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID) [Phase 2]

View source ↗

Summary

Trial update for ORCHID, a Phase 2 study assessing oral vinorelbine or capecitabine with trastuzumab as adjuvant therapy for lymph node–negative, HER2-positive,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Trastuzumab (trastuzumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING